Do you want to read an article? Please log in or register.
Efficacy and Safety of Sotatercept Across Ranges of Cardiac Index in Patients with Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR
Further Publications
Related content
RECOMMENDED
Pulmonary Hypertension
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of Phase 2, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Am J Respir Crit Care Med
Montani D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman AB, Escribano Subias P, Feldman J, Meyer GM, Olsson KM, Coulet F, Manimaran S, Zhao Y, Lau A, de Oliveira Pena J, Badesch DB, Humbert M
doi: 10.1164/rccm.202409-1698OC
RECOMMENDED
Pulmonary Hypertension
Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities: Data from interventional clinical trials
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Heart Lung Transplant
Rosenkranz S, Ghofrani HA, Hoeper MM, Langleben D, Hegab S, Rahner C, Richard JF, McLaughlin VV
doi: 10.1016/j.healun.2024.08.018
Interstitial Lung DiseasePulmonary Hypertension
Sotatercept for Connective Tissue Disease-Associated Pulmonary Arterial Hypertension with Concomitant Interstitial Lung Disease: Efficacy and Safety Insights
J Clin Med
Dagher C, Akiki M, Swanson K, Carollo B, Fiscus G, Farber HW, Parikh R
doi: 10.3390/jcm14155177
Pulmonary Hypertension
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model
Adv Ther
Alsumali A, McLaughlin V, Chevure J, Klok R, Zhang W, Martinez EC, Pausch C, De Oliveira Pena J, van de Wetering G, Jootun M, Lautsch D, Hoeper MM
doi: 10.1007/s12325-025-03241-4
Pulmonary Hypertension
A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension
Respir Med
Paoli CJ, Zhang C, Tang X, Panjabi S, Thompson A, El-Kersh K
doi: 10.1016/j.rmed.2025.108112
Pulmonary Hypertension
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework
Eur Respir Rev
Varian F, Burney R, Pearson C, Goh ZM, Newman J, Rawlings G, Zafar H, Kiely DG, Thompson AAR, Condliffe R, Toshner M, McCormack C, Armstrong I, Peasgood T, Carlton J, Rothman AMK
doi: 10.1183/16000617.0006-2025
Pulmonary Hypertension
Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
Lancet Respir Med
GBD 2021 Pulmonary Arterial Hypertension Collaborators
doi: 10.1016/S2213-2600(24)00295-9
Pulmonary Hypertension
Clinical Characteristics and Treatment of Patients Diagnosed with Pulmonary Arterial Hypertension: A Real-World Study in the USA, Europe and Japan
Adv Ther
Vizza CD, Klok R, Harley J, Small M, Scott M, Lautsch D, White RJ
doi: 10.1007/s12325-024-03026-1
Sleep Apnea
The efficacy and safety of an intraoral negative air pressure device in patients with obstructive sleep apnea: a systematic review and meta-analysis
J Clin Sleep Med
Puvatanond C, Kasemsuk N, Banhiran W
doi: 10.5664/jcsm.11812